نتائج البحث

Unraveling a novel therapeutic facet of Etravirine to confront Hepatocellular Carcinoma via disruption of cell cycle.

• Authors : Nair, Gouri¹ (AUTHOR); Saraswathy, G. R.² (AUTHOR); Aranjani, Jesil Mathew³ (AUTHOR)

• Source: Scientific Reports. 2/10/2025, Vol. 15 Issue 1, p1-23. 23p.

تفاصيل العنوان

New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

• Authors : Battaglia, Giulia¹ (AUTHOR) ; Lazzarotto, Davide¹ (AUTHOR) ; Tanasi, Ilaria² (AUTHOR)

• Source: Journal of Clinical Medicine. Feb2025, Vol. 14 Issue 3, p700. 10p.

تفاصيل العنوان

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients.

• Authors : Adoncecchi, Giacomo¹ (AUTHOR) ; Kumar, Ambuj² (AUTHOR) ; Mogili, Krishnakar¹ (AUTHOR)

• Source: Cancers. Jan2025, Vol. 17 Issue 2, p310. 11p.

تفاصيل العنوان

Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia.

• Authors : Tessier, Steven¹ (AUTHOR); McCullough, Kristen B.² (AUTHOR); Gangat, Naseema³ (AUTHOR)

• Source: Leukemia & Lymphoma. Jan2025, p1-5. 5p. 1 Illustration, 1 Chart.

تفاصيل العنوان

Zenocutuzumab-zbco Earns Accelerated Approval for Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer.

• Source: Oncology Practice Management. Jan2025, Vol. 15 Issue 1, p15-16. 2p.

تفاصيل العنوان

FDA Officials Grant Accelerated Approval to Zanidatamab-hrii for Previously Treated, Unresectable, Metastatic HER2-Positive Biliary Tract Cancer.

• Source: Oncology Practice Management. Jan2025, Vol. 15 Issue 1, p16-16. 1/3p.

تفاصيل العنوان

FDA Updates Drug Labeling for Fludarabine Phosphate Under Project Renewal.

• Source: Oncology Practice Management. Jan2025, Vol. 15 Issue 1, p16-16. 1/2p.

تفاصيل العنوان

Fixed-Duration Acalabrutinib/Venetoclax Combo Improves PFS in Frontline CLL.

• Authors : KAHL, KRISTIE L.

• Source: OncologyLive. Jan2025, Vol. 26 Issue 1, p61-66. 2p.

تفاصيل العنوان